Dramina tab. 50mg # 10
Category
Vomiting, nausea
Scope of the drug
Gastrointestinal tract
Release form
Tablet
Manufacturer country
Croatia
Package quantity, pcs
ten
Release form, composition and packaging
?
The tablets are white, round, flat, chamfered and scored on one side.
1 tab.
Dimenhydrinate 50 mg
lactose monohydrate, microcrystalline cellulose, magnesium stearate, povidone, crospovidone.
5 pieces.
- blisters (1) - cardboard packs.
10 pieces.
- blisters (1) - cardboard packs.
pharmachologic effect
A blocker of histamine H1 receptors with anticholinergic properties.
Reduces or eliminates histamine-induced increase in the tone of smooth muscles of the bronchi, intestines, uterus, increased capillary permeability with the development of edema, hyperemia and itching.
Dimenhydrinate has a pronounced sedative and antiemetic effect. ''
Indications for use
Prevention and symptomatic treatment of nausea, vomiting and dizziness of various origins (including with Meniere's disease, kinetosis).
Contraindications for use
Hypersensitivity to dimensionhydrinate, children under 1 year of age.
Dosage regimen
In adults, it is used at a dose of 50-100 mg 4-6 times / day.
The maximum daily dose is 400 mg.
In children aged 1-6 years, it is used at a dose of 12.5-25 mg 2-3 times / day, 7-12 years old - 25-50 mg 2-3 times / day.
Side effect
Possibly: dry mouth, poor accommodation, drowsiness.
Drug interactions
When used simultaneously with sedatives, hypnotics, antidepressants, ethanol, the depressing effect on the central nervous system is enhanced.
With the simultaneous use of dimensionhydrinate can mask the ototoxicity of streptomycin and, apparently, other antibiotics of the aminoglycoside group.
Application during pregnancy and lactation
During pregnancy and lactation (breastfeeding), dimensionhydrinate is used with caution, only in cases where the expected therapeutic effect for the mother outweighs the potential risk of side effects in the fetus or child. In experimental studies, it was found that dimensionhydrinate causes the development of cardiovascular defects and inguinal hernia in the fetus.
Special instructions Dimenhydrinate is used with caution in angle-closure glaucoma, urination disorders, benign prostatic hyperplasia, epilepsy, in patients with severe cardiovascular diseases.
During the period of treatment, alcohol should be avoided.
Influence on the ability to drive vehicles and control mechanisms Patients taking dimensionhydrinate should avoid engaging in potentially hazardous activities that require increased attention and speed of psychomotor reactions.
Name ENG
DRAMINA
Clinical and pharmacological group
The drug used for kinetosis
ATX code
Other antihistamines for systemic use
Dosage
50mg
Structure
1 tablet contains: active substance - dimensionhydrinate 50 mg
Excipients: lactose monohydrate - 112.86 mg
microcrystalline cellulose - 57.50 mg, magnesium stearate - 1,150 mg
povidone K30 - 4.247 mg
crospovidone - 4,247 mg.?
Indications
motion sickness (sea, car and air sickness)
prevention and treatment of symptoms of vestibular and labyrinthine disorders (dizziness, nausea, vomiting), with the exception of symptoms caused by anticancer therapy
Meniere's disease.
Storage conditions and periods
At a temperature not higher than 25 degrees.
Expiration date: 5 years
INN / Active ingredient
Dimenhydrinate
Specifications
Category
Vomiting, nausea
Scope of the drug
Gastrointestinal tract
Release form
Tablet
Manufacturer country
Croatia
Package quantity, pcs
ten
Scope of application
Gastroenterology
Minimum age from
3 years old
Way of introduction
Through the mouth
Vacation conditions
Without recipe
Brand name
Jadran
The amount of the dosage form in the primary package
10 pieces.
Primary packaging type
Blister
Type of consumer packaging
Pack of cardboard
Pharmaco-therapeutic group
H1-histamine receptor blocker
Anatomical and therapeutic characteristics
R06AX Other antihistamines for systemic use
Dosage form
Pills
The target audience
Children
Dosage (volume) of the substance in the preparation
Dimenhydrinate 50 mg
Expiration date in days
1825
Package weight, g
twenty
Mode of application
:
Inside, before eating: < br> - motion sickness (motion sickness, car sickness, air sickness): < br> children from 3 to 6 years old - 1/4 -1/2 tablets 2-3 times a day children from 7 to 12 years old - 1/2 - 1 tablet 2-3 times a day children over 12 years old and adults - 1-2 tablets 2-3 times a day < br> - prevention and treatment of symptoms of vestibular and labyrinth disorders (dizziness, nausea, vomiting), with the exception of symptoms caused by anticancer therapy: < br> children from 3 to 6 years old - 1/4 - 1/2 tablets 2-3 times a day children from 7 to 12 years old - 1 / 2-1 tablet 2-3 times a day children over 12 years old and adults - 1-2 tablets 2-3 times a day < br> - Meniere's disease: < br> children from 3 to 12 years old - 1 / 2-1 tablet 2-3 times a day children over 12 years old and adults 1-2 tablets 2-3 times a day. < br> The maximum daily dose for adults should not exceed 7 tablets. For the prevention of kinetosis, take 1-2 tablets 30 minutes before the trip. The duration of the drug use and the possibility of repeating the course of treatment - in agreement with the doctor.
Information on technical characteristics, delivery set, country of manufacture